GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Recce Pharmaceuticals Ltd (STU:R9Q) » Definitions » Market Cap

Recce Pharmaceuticals (STU:R9Q) Market Cap : €66.92 Mil (As of Dec. 13, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Recce Pharmaceuticals Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Recce Pharmaceuticals's share price for the quarter that ended in Dec. 2023 was €0.308. Recce Pharmaceuticals's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 203.70 Mil. Therefore, Recce Pharmaceuticals's market cap for the quarter that ended in Dec. 2023 was €62.74 Mil.

Recce Pharmaceuticals's quarterly market cap declined from Dec. 2022 (€73.66 Mil) to Jun. 2023 (€59.98 Mil) but then increased from Jun. 2023 (€59.98 Mil) to Dec. 2023 (€62.74 Mil).

Recce Pharmaceuticals's annual market cap declined from Jun. 2022 (€100.52 Mil) to Jun. 2023 (€59.98 Mil) but then increased from Jun. 2023 (€59.98 Mil) to Jun. 2024 (€71.80 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Recce Pharmaceuticals's Enterprise Value for Today is €64.73 Mil.


Recce Pharmaceuticals Market Cap Historical Data

The historical data trend for Recce Pharmaceuticals's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Recce Pharmaceuticals Market Cap Chart

Recce Pharmaceuticals Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Market Cap
Get a 7-Day Free Trial Premium Member Only 52.88 98.33 100.52 59.98 71.80

Recce Pharmaceuticals Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 100.52 73.66 59.98 62.74 71.80

Competitive Comparison of Recce Pharmaceuticals's Market Cap

For the Biotechnology subindustry, Recce Pharmaceuticals's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Recce Pharmaceuticals's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Recce Pharmaceuticals's Market Cap distribution charts can be found below:

* The bar in red indicates where Recce Pharmaceuticals's Market Cap falls into.



Recce Pharmaceuticals Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Recce Pharmaceuticals's Market Cap for the fiscal year that ended in Jun. 2024 is calculated as

Market Cap (A: Jun. 2024 )=Share Price (A: Jun. 2024 )*Shares Outstanding (EOP) (A: Jun. 2024 )
=€0.352*203.987
=€71.80

Recce Pharmaceuticals's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=€0.308*203.702
=€62.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Recce Pharmaceuticals  (STU:R9Q) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Recce Pharmaceuticals Market Cap Related Terms

Thank you for viewing the detailed overview of Recce Pharmaceuticals's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Recce Pharmaceuticals Business Description

Traded in Other Exchanges
Address
180 George Street, Level 23, Salesforce Tower, Sydney, NSW, AUS, 2000
Recce Pharmaceuticals Ltd is an Australia-based globally-focused biotechnology company engaged in the development and commercialization of a new class of antibiotics. The company operates in only one business segment being research and development of pharmaceutical drugs. The firm operates in three geographic segments being Australia, the United Kingdom, and the United States of America, of which the majority of the revenue comes from Australia. The company offers antibiotic drugs to treat diseases caused by various bacteria namely Sepsis, Neisseria gonorrhoeaei, Escherichia coli, Mycobacterium abscessus, and others.

Recce Pharmaceuticals Headlines

No Headlines